Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 7/2010

01-07-2010 | Article

Anthropometric measures and glucose levels in a large multi-ethnic cohort of individuals at risk of developing type 2 diabetes

Authors: L. de Koning, H. C. Gerstein, J. Bosch, R. Diaz, V. Mohan, G. Dagenais, S. Yusuf, S. S. Anand, for the EpiDREAM Investigators

Published in: Diabetologia | Issue 7/2010

Login to get access

Abstract

Aims/hypotheses

We determined: (1) which of BMI, waist circumference, hip circumference and WHR has the strongest association and explanatory power for newly diagnosed type 2 diabetes and glucose status; and (2) the impact of considering two measures simultaneously. We also explored variation in anthropometric associations by sex and ethnicity.

Methods

We performed cross-sectional analysis of 22,293 men and women who were from five ethnic groups and 21 countries, and at risk of developing type 2 diabetes. Standardised anthropometric associations with type 2 diabetes and AUC of glucose status from OGTT (AUCOGTT) were determined using multiple regression. Explanatory power was assessed using the c-statistic and adjusted r 2.

Results

An increase in BMI, waist circumference or WHR had similar positive associations with type 2 diabetes, AUCOGTT and explanatory power after adjustment for age, sex, smoking and ethnicity (p < 0.01). However, using BMI and WHR together resulted in greater explanatory power than with other models (p < 0.01). Associations were strongest when waist circumference and hip circumference were used together, a combination that had greater explanatory power than other models except for BMI and WHR together (p < 0.01). Results were directionally similar according to sex and ethnicity; however, significant variations in associations were observed among these subgroups.

Conclusions/interpretation

The combination of BMI and WHR, or of waist circumference and hip circumference has the best explanatory power for type 2 diabetes and glucose status compared with a single anthropometric measure. Measurement of waist circumference and hip circumference is required to optimally identify people at risk of type 2 diabetes and people with elevated glucose levels.
Appendix
Available only for authorised users
Literature
1.
2.
Kelly T, Yang W, Chen CS, Reynolds K, He J (2008) Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 32:1431–1437CrossRef
3.
4.
International Diabetes Federation (2006) Diabetes Atlas. International Diabetes Federation, Brussels
5.
Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMed
6.
Shai I, Jiang R, Manson JE et al (2006) Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care 29:1585–1590CrossRefPubMed
7.
Yusuf S, Hawken S, Ounpuu S et al (2005) Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study. Lancet 366:1640–1649CrossRefPubMed
8.
Pouliot MC, Despres JP, Nadeau A et al (1992) Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41:826–834CrossRefPubMed
9.
Meisinger C, Doring A, Thorand B, Heier M, Lowel H (2006) Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA/KORA Augsburg cohort study. Am J Clin Nutr 84:483–489PubMed
10.
Li C, Engstrom G, Hedblad B, Calling S, Berglund G, Janzon L (2006) Sex differences in the relationships between BMI, WHR and incidence of cardiovascular disease: a population-based cohort study. Int J Obes (Lond) 30:1775–1781CrossRef
11.
Karter AJ, Mayer-Davis EJ, Selby JV et al (1996) Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes 45:1547–1555CrossRefPubMed
12.
Harris MM, Stevens J, Thomas N, Schreiner P, Folsom AR (2000) Associations of fat distribution and obesity with hypertension in a bi-ethnic population: the ARIC study. Atherosclerosis Risk in Communities Study. Obes Res 8:516–524CrossRefPubMed
13.
Gerstein HC, Yusuf S, Holman R, Bosch J, Pogue J (2004) Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial. Diabetologia 47:1519–1527CrossRefPubMed
14.
15.
16.
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560CrossRefPubMed
17.
Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K (2007) Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 29:115–128CrossRefPubMed
18.
Qiao Q, Nyamdorj R (2010) Is the association of type II diabetes with waist circumference or waist-to-hip ratio stronger than that with body mass index? Eur J Clin Nutr 64:30–34
19.
Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB (2005) Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81:555–563PubMed
20.
Snijder MB, Dekker JM, Visser M et al (2004) Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care 27:372–377CrossRefPubMed
21.
Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE (2004) Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord 28:402–409CrossRefPubMed
22.
Lissner L, Bjorkelund C, Heitmann BL, Seidell JC, Bengtsson C (2001) Larger hip circumference independently predicts health and longevity in a Swedish female cohort. Obes Res 9:644–646CrossRefPubMed
23.
Seidell JC, Perusse L, Despres JP, Bouchard C (2001) Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr 74:315–321PubMed
24.
Canoy D, Boekholdt SM, Wareham N et al (2007) Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation 116:2933–2943CrossRefPubMed
25.
Allison DB, Paultre F, Goran MI, Poehlman ET, Heymsfield SB (1995) Statistical considerations regarding the use of ratios to adjust data. Int J Obes Relat Metab Disord 19:644–652PubMed
26.
Kamel EG, McNeill G, Han TS et al (1999) Measurement of abdominal fat by magnetic resonance imaging, dual-energy X-ray absorptiometry and anthropometry in non-obese men and women. Int J Obes Relat Metab Disord 23:686–692CrossRefPubMed
27.
Fox CS, Massaro JM, Hoffmann U et al (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48CrossRefPubMed
28.
Margolis KL, Bonds DE, Rodabough RJ et al (2004) Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47:1175–1187CrossRefPubMed
29.
Bonds DE, Lasser N, Qi L et al (2006) The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia 49:459–468CrossRefPubMed
30.
Katzmarzyk PT, Malina RM (1998) Obesity and relative subcutaneous fat distribution among Canadians of First Nation and European ancestry. Int J Obes Relat Metab Disord 22:1127–1131CrossRefPubMed
31.
Piers LS, Rowley KG, Soares MJ, O’Dea K (2003) Relation of adiposity and body fat distribution to body mass index in Australians of Aboriginal and European ancestry. Eur J Clin Nutr 57:956–963CrossRefPubMed
32.
Aloia JF, Vaswani A, Mikhail M, Flaster ER (1999) Body composition by dual-energy X-ray absorptiometry in black compared with white women. Osteoporos Int 10:114–119CrossRefPubMed
33.
Rush EC, Goedecke JH, Jennings C et al (2007) BMI, fat and muscle differences in urban women of five ethnicities from two countries. Int J Obes (Lond) 31:1232–1239CrossRef
34.
Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL (2007) Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 86:353–359PubMed
35.
Lear SA, Humphries KH, Kohli S, Birmingham CL (2007) The use of BMI and waist circumference as surrogates of body fat differs by ethnicity. Obesity (SilverSpring) 15:2817–2824CrossRef
36.
Keating BJ, Tischfield S, Murray SS et al (2008) Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS ONE 3:e3583CrossRefPubMed
37.
Bailey SD, Xie C, Do R, et al. (2009) Genetic variation at the NFATC2 locus iIncreases edema in the Diabetes REduction Assessment with Ramipril and Rosiglitazone Medication (DREAM) Study. The American Society of Human Genetics 59th Annual Meeting, Honolulu, HI, abstract no. 306
Metadata
Title
Anthropometric measures and glucose levels in a large multi-ethnic cohort of individuals at risk of developing type 2 diabetes
Authors
L. de Koning
H. C. Gerstein
J. Bosch
R. Diaz
V. Mohan
G. Dagenais
S. Yusuf
S. S. Anand
for the EpiDREAM Investigators
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1710-3

Other articles of this Issue 7/2010

Diabetologia 7/2010 Go to the issue

Article

Direct evidence for susceptibility genes for type 2 diabetes on mouse chromosomes 11 and 14

Article

Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes

Article

Beta cell coupling and connexin expression change during the functional maturation of rat pancreatic islets

Article

Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice

Research Letter

Hyperglycaemia and ketosis induced by gamma hydroxybutyrate (GHB)

Review

Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits